What is the primary goal of microvascular decompression (MVD)?

The primary goal of microvascular decompression (MVD) is to relieve nerve compression caused by adjacent blood vessels. This is typically achieved by placing a material, such as an Ivalon or Teflon pad, between the offending vessel and the nerve. This approach helps to alleviate the pressure that the vessel exerts on the nerve, which can lead to symptoms such as pain or neurological deficits.

By using a soft cushion to separate the vessel and the nerve, MVD aims to decompress the nerve without damaging it or performing a more invasive intervention. This method is particularly effective for treating conditions such as trigeminal neuralgia, where vascular compression of the trigeminal nerve is the underlying cause of symptoms.

In contrast, the other options do not represent the main intention of MVD. Reattaching damaged nerves or performing nerve resection would not address the underlying issue of vascular compression. Similarly, enhancing blood flow is not the goal of the procedure, as the focus is on reducing pressure on the nerve rather than increasing blood supply.